LGR5
Basic information
Region (hg38): 12:71439798-71586310
Previous symbols: [ "GPR67", "GPR49" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LGR5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 43 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 6 | 3 |
Variants in LGR5
This is a list of pathogenic ClinVar variants found in the LGR5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-71440117-C-A | not specified | Uncertain significance (Jul 19, 2023) | ||
12-71440214-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
12-71504624-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
12-71504657-C-A | not specified | Uncertain significance (Dec 01, 2022) | ||
12-71504658-T-G | not specified | Uncertain significance (Jan 02, 2024) | ||
12-71504663-A-T | not specified | Uncertain significance (Jan 16, 2024) | ||
12-71524406-A-G | not specified | Likely benign (Aug 21, 2023) | ||
12-71535142-C-T | Likely benign (Jun 12, 2018) | |||
12-71535175-C-A | not specified | Uncertain significance (Feb 02, 2024) | ||
12-71535176-C-T | not specified | Uncertain significance (Oct 06, 2023) | ||
12-71553092-A-C | not specified | Uncertain significance (Jun 29, 2022) | ||
12-71553245-A-T | not specified | Uncertain significance (Mar 29, 2022) | ||
12-71553284-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
12-71556627-A-G | Likely benign (Aug 01, 2018) | |||
12-71556628-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
12-71556630-A-C | not specified | Uncertain significance (Dec 09, 2023) | ||
12-71556641-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
12-71556642-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
12-71556676-C-G | not specified | Uncertain significance (Jun 19, 2024) | ||
12-71566905-C-G | not specified | Uncertain significance (Dec 12, 2022) | ||
12-71566909-T-G | not specified | Uncertain significance (Jun 05, 2024) | ||
12-71572858-G-A | not specified | Uncertain significance (Oct 27, 2023) | ||
12-71572861-A-G | Likely benign (Jun 08, 2018) | |||
12-71572878-A-T | not specified | Uncertain significance (May 29, 2024) | ||
12-71577963-A-G | not specified | Uncertain significance (Aug 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LGR5 | protein_coding | protein_coding | ENST00000266674 | 18 | 146541 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.50e-8 | 0.999 | 125685 | 0 | 63 | 125748 | 0.000251 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.144 | 474 | 465 | 1.02 | 0.0000235 | 5890 |
Missense in Polyphen | 142 | 175.09 | 0.81099 | 2387 | ||
Synonymous | -0.299 | 197 | 192 | 1.03 | 0.0000105 | 1825 |
Loss of Function | 2.92 | 19 | 38.5 | 0.493 | 0.00000182 | 496 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000537 | 0.000536 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000327 | 0.000325 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for R-spondins that potentiates the canonical Wnt signaling pathway and acts as a stem cell marker of the intestinal epithelium and the hair follicle. Upon binding to R- spondins (RSPO1, RSPO2, RSPO3 or RSPO4), associates with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. In contrast to classical G-protein coupled receptors, does not activate heterotrimeric G-proteins to transduce the signal. Involved in the development and/or maintenance of the adult intestinal stem cells during postembryonic development. {ECO:0000269|PubMed:21693646, ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076, ECO:0000269|PubMed:22815884, ECO:0000269|PubMed:23809763}.;
- Pathway
- Signaling by WNT;Signal Transduction;Regulation of FZD by ubiquitination;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.396
- rvis_EVS
- 1.56
- rvis_percentile_EVS
- 95.68
Haploinsufficiency Scores
- pHI
- 0.639
- hipred
- Y
- hipred_score
- 0.591
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.621
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lgr5
- Phenotype
- renal/urinary system phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- hair follicle development;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;hormone-mediated signaling pathway;oocyte differentiation;regulation of cell population proliferation;inner ear development;positive regulation of canonical Wnt signaling pathway;epithelial cell proliferation involved in renal tubule morphogenesis
- Cellular component
- plasma membrane;integral component of plasma membrane;trans-Golgi network membrane
- Molecular function
- transmembrane signaling receptor activity;G protein-coupled receptor activity;protein binding;G protein-coupled peptide receptor activity;protein-hormone receptor activity